Bilateral Benefit in Adult Users of the HiRes 90K Bionic Ear System
NCT ID: NCT00205881
Last Updated: 2012-03-01
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
32 participants
INTERVENTIONAL
2004-10-31
2009-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Implantation of the HiRes90K™ Advantage Cochlear Implant With HiFocus™ Mid-Scala and Development of a Combined Electric and Acoustic Stimulation Technology in Adults With Partial Deafness
NCT02189798
Combined Acoustic and Electric Hearing (CI/HA) in Adult Bimodal Users Using a HA With a Bimodal Fitting Formula
NCT03142100
Assessment of Bimodal Contribution in Adult Cochlear Implant Users
NCT02331017
Investigating Hearing Aid Frequency Response Curves 2
NCT05828017
Evaluation of Hearing Preservation in Adults With Partial Low-Frequency Hearing Implanted With the HiFocus™ Mid-Scala Electrode
NCT01959152
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Bilaterally Implanted with HiRes 90K device.
HiRes 90K Bionic Ear System
Cochlear implant system
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HiRes 90K Bionic Ear System
Cochlear implant system
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Age 18 years or older.
3. Postlingual onset of hearing loss.
4. Sensorineural hearing loss of a severe or greater degree in both ears.
5. Normal/patent cochlear anatomy in each ear.
6. English language proficiency.
7. Willingness and ability to participate in all scheduled procedures.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Advanced Bionics
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mary Joe Osberger
Role: STUDY_CHAIR
Advanced Bionics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
House Clinic/House Ear Institute
Los Angeles, California, United States
California Ear Institute (Let Them Hear Foundation)
Palo Alto, California, United States
University of Miami - Cochlear Implant Center
Miami, Florida, United States
Tampa Bay Hearing and Balance Center
Tampa, Florida, United States
Carle Clinic Association
Urbana, Illinois, United States
Spectrum Health
Grand Rapids, Michigan, United States
Midwest Ear Institute
Kansas City, Missouri, United States
New York University Cochlear Implant Center
New York, New York, United States
Dallas Otolaryngology Associates
Dallas, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AUD-BL-070705
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.